FierceBiotech

Strand's Big Pharma-backed series B brings in $153M to advance mRNA tumor drugs

An impressive array of Big Pharma backers lined up to ensure Strand Therapeutics has the funding needed to take its mRNA-based solid tumor drug further into the clinic. New Strand supporters that ...
Business Wire

Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, announced today preclinical data from its programmable mRNA ...
Business Wire

Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for Solid Tumors

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the world’s first programmable mRNA company developing curative therapies for cancer, autoimmune diseases, and beyond, today announced the first patient ...
The Business Journals

MIT spinout raises $153M for 'programmable' mRNA drugs

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boston biotech that was born ...
STAT

Scientists show that mRNA therapy can be delivered as a capsule

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. An oral capsule can efficiently deliver liquid mRNA therapy directly to the gut, a possible new ...